Generation Bio, which once raised over $235 million from major investors like Fidelity and T. Rowe Price before going public ...

A 15-year agreement between the UK Nuclear Decommissioning Authority and biotech firm Bicycle Therapeutics focuses on ...

Despite lagging the Dow Jones Industrial Average over the past year, Charles River Laboratories continues to attract cautious ...

AL AIN, 16th December, 2025 (WAM) -- The Khalifa Centre for Genetic Engineering & Biotechnology (KCGEB) continues to drive the UAE’s leadership in genomics and biotechnology by transforming scientific ...

A new doctoral training centre based at Queen’s University Belfast will help to train the next generation of experts in ...

Nektar Therapeutics is planning to bring its interleukin-2-targeting drug candidate into a phase 3 trial for severe alopecia ...

New research from the University of Virginia School of Medicine is revealing why traumatic brain injury increases the chance ...

Siemens Healthineers has tapped the Alzheimer’s disease blood test developer ALZpath for an in vitro diagnostic to ...

UK-based Bicycle Therapeutics, a pharma company developing a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, has entered into a 15-year ...

A total of 17 individuals, including two Pune-based doctors associated with a private laboratory, have been booked by the ...

Italy, renowned as a 'land of gourmets,' is developing technology to create useful food for resource-limited environments ...